Literature DB >> 6629324

Chemoprotective effects of two dithiolthiones and of butylhydroxyanisole against carbon tetrachloride and acetaminophen toxicity.

S S Ansher, P Dolan, E Bueding.   

Abstract

Administration of tert-butyl-4-hydroxyanisole or of two dithiolthiones to female CD-1 mice protected against the acute toxic effects of two hepatotoxic agents, acetaminophen and carbon tetrachloride. Reduced mortality of mice was observed following pretreatment with tert-butyl-4-hydroxyanisole or dithiolthiones. Pretreatment reduced or prevented hepatic glutathione depletion produced by these two hepatotoxic agents. Liver damage, i.e., as determined by serum transaminase and sorbitol dehydrogenase activities, was less after pretreatment with tert-butyl-4-hydroxyanisole or dithiolthiones. Administration of dithiolthiones resulted in increased (from four- to over six-fold) activities of liver glutathione-S-transferases.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6629324     DOI: 10.1002/hep.1840030608

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  20 in total

1.  Anethole dithiolethione lowers the homocysteine and raises the glutathione levels in solid tissues and plasma of rats: a novel non-vitamin homocysteine-lowering agent.

Authors:  Daniela Giustarini; Paolo Fanti; Anna Sparatore; Elena Matteucci; Ranieri Rossi
Journal:  Biochem Pharmacol       Date:  2014-03-14       Impact factor: 5.858

2.  Induction of NAD(P)H:quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: a model system for the study of anticarcinogens.

Authors:  M J De Long; H J Prochaska; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

3.  Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.

Authors:  P J O'Dwyer; C E Szarka; K S Yao; T C Halbherr; G R Pfeiffer; F Green; J M Gallo; J Brennan; H Frucht; E B Goosenberg; T C Hamilton; S Litwin; A M Balshem; P F Engstrom; M L Clapper
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

Review 4.  Targeting NRF2 signaling for cancer chemoprevention.

Authors:  Mi-Kyoung Kwak; Thomas W Kensler
Journal:  Toxicol Appl Pharmacol       Date:  2009-09-02       Impact factor: 4.219

Review 5.  Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology.

Authors:  Thomas W Kensler; Bill D Roebuck; Gerald N Wogan; John D Groopman
Journal:  Toxicol Sci       Date:  2010-09-29       Impact factor: 4.849

6.  Rapid detection of inducers of enzymes that protect against carcinogens.

Authors:  H J Prochaska; A B Santamaria; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 7.  Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2.

Authors:  Qiang Ma; Xiaoqing He
Journal:  Pharmacol Rev       Date:  2012-09-10       Impact factor: 25.468

8.  The Nrf2 activator oltipraz also activates the constitutive androstane receptor.

Authors:  Matthew D Merrell; Jonathan P Jackson; Lisa M Augustine; Craig D Fisher; Angela L Slitt; Jonathan M Maher; Wendong Huang; David D Moore; Youcai Zhang; Curtis D Klaassen; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2008-05-12       Impact factor: 3.922

9.  Clinical pharmacology studies of oltipraz--a potential chemopreventive agent.

Authors:  N V Dimitrov; J L Bennett; J McMillan; M Perloff; C M Leece; W Malone
Journal:  Invest New Drugs       Date:  1992-11       Impact factor: 3.850

Review 10.  Nrf2 in liver toxicology.

Authors:  Keiko Taguchi; Thomas W Kensler
Journal:  Arch Pharm Res       Date:  2019-11-28       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.